Evidence map›Paper›PMID 29183387›Full record

ArticleBreast cancer research : BCR2017

Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events.

Lucy C de Jong, Simone Cree, Vanessa Lattimore, George A R Wiggins, Amanda B Spurdle, kConFab Investigators, Allison Miller, Martin A Kennedy, Logan C Walker

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. A Molecular Characterization of the Allelic Expression of theInternational journal of molecular sciences · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Lucy C de JongDepartment of Pathology, University of Otago, Christchurch, New Zealand.
Simone CreeDepartment of Pathology, University of Otago, Christchurch, New Zealand.
Vanessa LattimoreDepartment of Pathology, University of Otago, Christchurch, New Zealand.
George A R WigginsDepartment of Pathology, University of Otago, Christchurch, New Zealand.
Amanda B SpurdleGenetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Queensland, Australia.
kConFab Investigators
Allison MillerDepartment of Pathology, University of Otago, Christchurch, New Zealand.
Martin A KennedyDepartment of Pathology, University of Otago, Christchurch, New Zealand.
Logan C WalkerDepartment of Pathology, University of Otago, Christchurch, New Zealand. logan.walker@otago.ac.nz.
University of Otago · NZQIMR Berghofer Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLaboratory assays evaluating the effect of DNA sequence variants on BRCA1 mRNA splicing may contribute to classification by providing molecular evidence. However, our knowledge of normal and aberrant BRCA1 splicing events to date has been limited to data derived from assays targeting partial transcript sequences. This study explored the utility of nanopore sequencing to examine whole BRCA1 mRNA transcripts and to provide accurate categorisation of in-frame and out-of-frame splicing events.

methodsThe exon structure of BRCA1 transcripts from a previously studied control lymphoblastoid cell line were assessed using MinION nanopore sequencing of long-range reverse transcriptase-PCR amplicons.

resultsOur study identified and characterised 32 complete BRCA1 isoforms, including 18 novel isoforms which showed skipping of multiple contiguous and/or non-contiguous exons. Furthermore, we show that known BRCA1 exon skipping events, such as Δ(9,10) and Δ21, can co-occur in a single transcript, with some isoforms containing four or more alternative splice junctions. Fourteen novel isoforms were formed entirely from a combination of previously identified alternative splice junctions, suggesting that the total number of BRCA1 isoforms might be lower than the number of splicing events reported previously.

conclusionsOur results highlight complexity in BRCA1 transcript structure that has not been described previously. This finding has key implications for predicting the translation frame of splicing transcripts, important for interpreting the clinical significance of spliceogenic variants. Future research is warranted to quantitatively assess full-length BRCA1 transcript levels, and to assess the application of nanopore sequencing for routine evaluation of potential spliceogenic variants.

Indexed as

Alternative SplicingExonsGenes, BRCA1High-Throughput Nucleotide SequencingBase SequenceCell Line, TumorDNA, ComplementaryFemaleHumansNonsense Mediated mRNA DecayRNA, MessengerDNA, ComplementaryRNA, MessengerBRCA1Exon skippingFull-length transcriptMinIONNanopore sequencingSplicing

Identifiers

PMID29183387
PMCPMC5706335
OpenAlexW2952864567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.